Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-11-24
2000-12-05
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142365, A61K 31415, A61P 1707
Patent
active
061567817
ABSTRACT:
A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR1## wherein R.sup.2 is selected from hydrido, alkyl, haloalkyl, alkoxycarbonyl, cyano, cyanoalkyl, carboxyl, aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl, arylaminocarbonyl, carboxyalkylaminocarbonyl, carboxyalkyl, aralkoxycarbonylalkylaminocarbonyl, aminocarbonylalkyl, alkoxycarbonylcyanoalkenyl and hydroxyalkyl; wherein R.sup.3 is selected from hydrido, alkyl, cyano, hydroxyalkyl, cycloalkyl, alkylsulfonyl and halo; and wherein R.sup.4 is selected from aralkenyl, aryl, cycloalkyl, cycloalkenyl and heterocyclic; wherein R.sup.4 is optionally substituted at a substitutable position with one or more radicals selected from halo, alkylthio, alkylsulfonyl, cyano, nitro, haloalkyl, alkyl, hydroxyl, alkenyl, hydroxyalkyl, carboxyl, cycloalkyl, alkylamino, dialkylamino, alkoxycarbonyl, aminocarbonyl, alkoxy, haloalkoxy, sulfamyl, heterocyclic and amino; provided R.sup.2 and R.sup.3 are not both hydrido; further provided that R.sup.2 is not carboxyl or methyl when R.sup.3 is hydrido and when R.sup.4 is phenyl; further provided that R.sup.4 is not triazolyl when R.sup.2 is methyl; further provided that R.sup.4 is not aralkenyl when R.sup.2 is carboxyl, aminocarbonyl or ethoxycarbonyl; further provided that R.sup.4 is not phenyl when R.sup.2 is methyl and R.sup.3 is carboxyl; and further provided that R.sup.4 is not unsubstituted thienyl when R.sup.2 is trifluoromethyl; or a pharmaceutically-acceptable salt thereof.
REFERENCES:
patent: 3940418 (1976-02-01), Hamilton
patent: 4146721 (1979-03-01), Rainer
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5315012 (1994-05-01), Connolly et al.
patent: 5387693 (1995-02-01), Connolly et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5504215 (1996-04-01), Talley et al.
patent: 5510496 (1996-04-01), Talley et al.
patent: 5521207 (1996-05-01), Talley et al.
R. Soliman et al, J. Pharm. Sci., 76, 626 (1987).
H. Mokhtar, Pak. J. Sci. ind. Res., 31, 762 (1988).
H. Mokhtar et al, Pak. J. Sci. Ind. Res., 34, 9 (1991).
M. Cocco et al, I1. Farmaco-Ed. Sci., 40, 272 (1985).
R. Soliman et al, J. Pharm. Sci., 72, 1004 (1983).
H. Feid-Allah, Pharmazie, 36, 754 (1981).
R. Soliman et al, J. Pharm. Sci., 70, 602 (1981).
Maybridge Chemical Co./Ryan Scientific Catalog, Compound No. BTB 06812.
H. Mokhtar et al, Pak. J. Sci. Ind. Res., 33:30-36 (1990).
H. Mokhtar et al, J. Chem. Soc. Pak., 10:414-424 (1988).
R. Soliman et al, J. Pharm. Sci., 72:999-1004 (1983).
M.S. I. Makki et al, Chem. Abstracts, 121:134017 (1994).
R. Hamilton, J. Heterocyclic Chem., 13, 545 (1976).
M. Hashem et al, J. Med. Chem., 19, 229 (1976).
H. Feid-Allah, J. Heterocyclic Chem., 18, 1561 (1981).
H. Mokhtar et al, Pharmazie, 33, 649 (1978).
R. Soliman et al, Pharmazie, 33 (1978).
Bertenshaw Stephen R
Carter Jeffery S
Collins Paul W
Docter Stephen H.
Graneto Matthew J
Bulock Joseph W.
G. D. Searle & Co.
Ramsuer Robert W.
LandOfFree
Substituted pyrazolyl benzenesulfonamides for the treatment of i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazolyl benzenesulfonamides for the treatment of i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolyl benzenesulfonamides for the treatment of i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-962153